substance use disorder

Receipt of Pharmacotherapy and Healthcare Utilization Among US Adults with Alcohol or Opioid Use Disorder: Insights from 2022-2023 National Data

By MedXY 09/03/2026

Few US adults with alcohol or opioid use disorder reported addiction pharmacotherapy use in 2022-2023. Pharmacotherapy receipt was linked to increased healthcare utilization, underscoring the need for early outpatient intervention strategies.

Diabetes & Endocrinology news Psychiatry

GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study

By MedXY 08/10/2026

This Swedish register-based study reveals that GLP-1 receptor agonists are associated with significantly reduced hospitalisations for alcohol and substance use disorders during treatment, with some lasting benefits after discontinuation of therapy for alcohol use disorder.

news Psychiatry Public Health

Spirituality as a Protective Factor Against Substance Use Disorders: Evidence from a 21st-Century Meta-Analysis

By MedXY 02/19/2026

A comprehensive meta-analysis of longitudinal studies involving over 540,000 participants reveals that spirituality and religious involvement are associated with a 13-18% reduction in harmful alcohol and drug use, offering significant implications for clinical prevention and recovery strategies.

news Psychiatry

Psychosocial Interventions for Dual-Diagnosis Schizophrenia: A Critical Appraisal of Efficacy and the Urgent Need for Innovation

By MedXY 02/05/2026

A comprehensive meta-analysis in JAMA Psychiatry reveals that current psychosocial interventions for schizophrenia and co-occurring substance use disorders offer negligible impact on symptoms and no significant effect on substance use reduction, with the notable exception of nicotine cessation strategies.

news Psychiatry Public Health

Stopping Smoking Is Associated With Better Recovery From Other Substance Use Disorders: Longitudinal Evidence From a US National Cohort

By MedXY 11/14/2025

A longitudinal, nationally representative cohort study found that within-person transition from current to former cigarette smoking was associated with a 30–43% higher odds of sustained recovery from other substance use disorders, supporting integration of smoking cessation into SUD care.

news Psychiatry Public Health

Telehealth Prescribing of ADHD Stimulants: Assessing Risks for Subsequent Substance Use Disorders

By MedXY 10/30/2025

This study evaluates whether initiating ADHD stimulant prescriptions via telehealth affects later risks of stimulant or other substance use disorders, finding no SUD risk increase but a potential rise in stimulant use disorder risk.

Clinical Updates news Psychiatry Specialties

Heart Rate Variability Biofeedback in Substance Use Disorder: Emerging Evidence from a Randomized Clinical Trial and Contextual Review

By MedXY 10/01/2025

Second-generation heart rate variability biofeedback (HRVB) shows promise in reducing craving, negative affect, and substance use in adults with substance use disorder (SUD), supporting its potential as an adjunctive treatment in early recovery.

Clinical Updates news Psychiatry Specialties

E-cigarettes versus Combination Nicotine Replacement Therapy for Smoking Cessation in Substance Use Disorder Patients: Integrative Analysis of Recent Trials and Longitudinal Patterns

By MedXY 08/02/2025

Recent trials show no significant difference in smoking cessation rates between e-cigarettes and combination nicotine replacement therapy among patients discharged from inpatient substance use withdrawal services. Longitudinal analyses reveal variable abstinence trajectories in e-cigarette trials, underscoring the need for further relapse-focused research.